Related Experiment Videos
Implications for Australia of the multimodal treatment study of children with attention-deficit/hyperactivity
1School of Psychiatry, University of New South Wales, and Avoca Clinic, Prince of Wales Hospital, Randwick, Australia. f.levy@unsw.edu.au
Insights
The Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA) found combined treatments effective for ADHD, influencing Australian clinical service planning. Further research is needed on ethical considerations and technological advancements in child psychiatry.
Area of Science:
- Child and Adolescent Psychiatry
- Behavioral Science
- Health Services Research
Background:
- The Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA) is a large-scale study with significant implications for clinical services.
- Attention-deficit/hyperactivity disorder (ADHD) affects numerous children, necessitating effective treatment and service planning.
Purpose of the Study:
- To review the implications of the USA MTA study for planning clinical services for children with ADHD in Australia.
- To examine the findings of the MTA study regarding treatment efficacy and their relevance to Australian service delivery.
- To discuss ethical, philosophical, and technological considerations impacting ADHD services.
Main Methods:
- Analysis of MTA study findings comparing medication alone versus combined medication and behavior therapy.
- Discussion of Australian service traditions, workforce, diagnostic, ethical, and philosophical factors.
- Examination of pharmacogenomic research and its implications for ADHD treatment.
Main Results:
- Combined treatments enable lower medication doses and are effective for comorbid ADHD symptoms.
- Multimodal treatments show efficacy for complex cases.
- Technological advancements, including pharmacogenomics, are poised to influence future ADHD management.
Conclusions:
- The MTA study highlights the need for careful service planning and consideration of the optimal level of medicalization in ADHD care.
- Ethical and philosophical debates surrounding medication use for subthreshold symptoms and socialization are crucial.
- Child psychiatrists must engage with technological advancements to inform future practice and policy.
Objectives:
This paper reviews the implications of the large-scale USA Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA) by the MTA Cooperative group for planning of clinical services for children with attention deficit hyperactivity disorder in Australia.
Method:
The MTA study findings of no significant difference between active medication treatment alone, and combined medication combined with behaviour therapy treatments, on core symptom outcomes, are examined. Service traditions, workforce issues, diagnostic and ethical and philosophical considerations are discussed in relation to their impact on service planning in Australia. Implications of pharmacogenomic research are examined. Ethical and philosophical questions are raised in relation to the use of stimulant medications for subthreshold symptoms and for socialization of children.
Results:
A critical evaluation of results reveals that combined treatments allow the use of lower medication doses, and that multimodal treatments are effective for comorbid symptoms. Completion of the Human Genome Project promises increasing technological advances. Arguments for and against a technological approach to child rearing are posited.
Conclusions:
The MTA study raises not just service planning questions, but also important ethical and philosophical considerations about optimal degree of medicalization of services in an increasingly technological society. Child psychiatrists will be required to have an understanding of technological developments if they wish to contribute to future debates.